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Purpose: To establish a novel murine intraocular lens (IOL) implantation model to study the protective effects of colored-
IOLs against retinal phototoxicity.
Methods: Two-millimeter diameter IOL buttons were created from IOLs for clinical use. Extra-capsular crystalline lens
extraction and IOL implantation were performed in BALB/c mice using a technique similar to human cataract surgery.
For light exposure experiments, mice were exposed to 5,000 LUX of white light for 24 h on the day after surgery. To
investigate the protective effects of yellow IOL against light exposure, ERG measurements were conducted in vivo,
followed by TdT-mediated dUTP Nick-End Labeling (TUNEL) and outer nuclear layer (ONL) thickness measurement
of retinal tissue in yellow or clear IOL-implanted mice and control mice without surgery.
Results: IOLs were successfully implanted in all animals, and IOL buttons without haptics were well stabilized in the
capsular bag. Murine eyes developed posterior capsule opacification (PCO) after IOL implantation by postoperative day
5 at the latest. In contrast to the clear IOL-implanted animals stimulated by light exposure, the yellow IOL-implanted
animals had significantly reduced numbers of TUNEL-positive cells and retained thickness of the ONL. The ERG showed
that yellow IOL implantation prevents a decrease of amplitude in both the a-wave and b-wave compared with clear IOL
implantation.
Conclusions: We established a new animal model of IOL implantation and demonstrated the protective effects of colored-
IOL against retinal phototoxicity after cataract surgery.
Improvements  in  cataract  surgery  lead  to  better
postoperative vision with lower complication rates; however,
visual  outcomes  may  still  be  compromised  by  certain
postoperative changes, such as posterior capsule opacification
(PCO)  and  cystoid  macular  edema  [1,2].  In  addition,  the
change in light transmission range between pre- and post-
cataract  surgery  is  thought  to  be  associated  with  another
postoperative  complication:  development  of  age-related
macular degeneration (AMD) [3]. AMD is the leading cause
of severe vision loss in people over age 50 in developed
countries [4]. Several lines of evidence indicate that retinal
phototoxicity,  which  induces  reactive  oxygen  species  and
results in tissue damage, is involved in the development of
AMD after cataract surgery [5]. Under normal conditions, the
sensory retina is protected from ultraviolet light (UV, 100–
400 nm) by the cornea and crystalline lens [6]. Aging can also
cause the crystalline lens to filter higher frequency visible
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light  (400–500  nm),  i.e.,  violet  or  blue  [7].  Therefore,
crystalline lens extraction during cataract surgery enables UV
and short wavelength visible light, which are implicated in
phototoxicity, to reach the retina.
The Beaver Dam Eye Study showed that cataract surgery
was  associated  with  a  fourfold  increase  in  the  risk  of
neovascular  AMD  and  a  threefold  increase  in  geographic
atrophy 10 years later [8,9]. Similar findings were reported in
the Blue Mountains Eye Study [10,11]. In accordance with the
clinical data, it was shown in vitro that blue light (441 nm),
which is in the short wavelength of visible light, is the most
harmful to photoreceptors and the retinal pigment epithelium
(RPE) [12]. Thus, it is likely that retinal phototoxicity is one
of the pivotal causes of AMD.
Elucidating the mechanisms underlying the postoperative
threats to vision relevant to cataract surgery has been of great
interest, and several experimental animal models have been
established  using  in  vivo  and  in  vitro  techniques  for  that
purpose [13,14]. In the past, rabbit and rat models in which
the animals wore an external, colored filter absorbing blue
light were used to evaluate the protective effect of yellow-
tinted intraocular lenses (IOL) against white light [15,16].
Since the rat crystalline lens, for example, stably transmits a
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2751significant percentage of light with wavelengths ranging from
350  nm  to  the  end  of  the  visible  spectrum  [16],  short
wavelength light can transmit in the presence of the crystalline
lens. Therefore, in the case of rat eyes, it may not be necessary
to remove the crystalline lens to conduct the phototoxicity
study [16]. However, since the rat crystalline lens still absorbs
part of the blue light [16], this led us to the idea that an animal
model with lens extraction and IOL insertion may be a more
realistic model for the investigation of retinal phototoxicity
after cataract surgery. Furthermore, IOL implantation would
make possible the evaluation of the protective effect of IOLs
with  different  spectral  transmissions  against  light-induced
retinal degeneration.
In the current study, we establish a novel murine IOL
implantation model and study the impact of a colored-IOL on
retinal phototoxicity compared with a clear IOL. Our murine
model,  involving  both  crystalline  lens  removal  and  IOL
implantation, mimics more closely the conditions after human
cataract surgery.
METHODS
Animals: A total of 83 BALB/c male mice (6 weeks old; n=17
for control and 66 for IOL implantation; Clea, Tokyo, Japan)
were used in this study. Animals were housed in plastic cages
in a climate-controlled animal facility and kept under dim
cyclic light (5 LUX, 12 h on/off) in our institution, except
where  otherwise  indicated.  All  animal  experiments  were
conducted in accordance with the Association for Research in
Vision and Ophthalmology (ARVO) Statement for the Use of
Animals in Ophthalmic and Vision Research.
IOLs: A conventional clear IOL (SA60AT) or blue light- and
UV-absorbing  yellow  IOL  (SN60AT)  was  used  for  the
following experiments [17]. The IOLs were kindly given by
Alcon Laboratories, Inc. (Fort Worth, TX). While the clear
IOL  transmits  more  than  90%  of  the  400  nm  and  longer
wavelengths, it blocks ultraviolet (UV) light [18]. In contrast,
the yellow IOL also absorbs wavelengths corresponding to
blue light (400–500 nm), similar to the spectral transmittance
of the adult human crystalline lens [18]. Compared with the
clear IOL, the yellow IOL reduces 71% of the transmittance
at 400 nm [18].
Extra-capsular  crystalline  lens  extraction  and  IOL
implantation: Mice were anesthetized with an intramuscular
injection of a mixture of 80 mg/kg Ketamine and 16 mg/kg
Xylazine  before  surgical  procedures.  Pupils  were  dilated
using  0.5%  Tropicamide  and  0.5%  Phenylephrine
Hydrochloride  (Mydrin-P;  Santen  Pharmaceutical,  Osaka,
Japan).  The  operation  was  conducted  under  a  surgical
microscope  (Leica  MZ16,  Leica  Microsystems,  Wetzlar,
Germany) with a light source (Leica CLS 150 XD, Leica), and
the  surgical  time  was  approximately  15  min  per  eye.
Paracentesis  was  performed  with  a  22.5°  knife  (MST22;
MANI,  Tochigi,  Japan;  Figure  1A),  and  1%  Sodium
Hyaluronate (OPEGAN Hi; Santen Pharmaceutical, Osaka,
Japan) was injected into the anterior chamber. The corneal
incision was extended to approximately 90° using Vannas
scissors (Geuder, Heidelberg, Germany;  Figure 1B,C), and
anterior curvilinear continuous capsulorrhexis was made with
Jewelers  Forceps  (Katena,  Denville,  NJ;  Figure  1D).
Thereafter, hydrodissection was performed with a 30-gauge
cannula to deliver the lens en bloc (Figure 1E). The lens cortex
was aspirated through the cannula (Figure 1F).
The central portion of the IOL optic was trephined with
a 2 mm diameter biopsy punch (Kai, Gifu, Japan; Figure 1G).
The  IOL  button  was  folded  by  forceps  (Figure  1H)  and
inserted into the capsular bag through the corneal incision
(Figure 1I). After IOL insertion, residual viscoelastic material
was replaced with phosphate buffered saline (PBS; Figure 1J).
To close the corneal wound, 3 to 5 interrupted 11–0 nylon
sutures (0550s; MANI) were placed (Figure 1K). To prevent
postoperative inflammation and infection, we administered
topical  antibiotics  (levofloxacin)  and  corticosteroids
(betamethasone) at the end of the surgery. The animals with
endophthalmitis or IOL implantation failure were excluded
from the study. All of the surgeries were performed by the
same investigator (M.O.) and involved one eye per animal –
the right eye.
In this new model, to clarify the time course of PCO
development,  one  of  the  most  frequent  postoperative
complications of cataract surgery, paraffin sections of IOL-
implanted  eyes  were  prepared  using  standard  techniques.
Hematoxylin and eosin (H&E) staining was also performed.
Briefly, at 1 and 5 days after IOL implantation, eyes were
enucleated from the animals under deep anesthesia and fixed
in 4% paraformaldehyde (PFA). After fixation, tissues were
processed and embedded in paraffin. Five-µm sections from
the middle portion of the eye were prepared and stained with
H&E.
Light exposure: For light exposure experiments, mice were
exposed to 5,000 LUX of white light for 24 h in a dedicated
exposure box, having stainless mirrors at the lateral sides and
floors (Tinker-N, Kyoto, Japan). The box contained a white
fluorescent lamp (FHD100ECW, Panasonic, Osaka, Japan)
and an air conditioner unit to maintain the temperature inside
at 23 °C. Prior to the light exposure, mice were dark adapted
for 12 h. The pupils were then dilated with a mixed solution
of 0.5% Tropicamide and 0.5% Phenylephrine just before the
light exposure.
TdT-mediated dUTP nick-end labeling (TUNEL): Mice were
anesthetized with pentobarbital sodium (70 mg/kg BW) and
perfused  with  10  ml  of  PBS  48  h  after  the  start  of  light
exposure. Subsequently, eyes were enucleated and fixed in
4%  PFA  overnight  at  4  °C.  After  fixation,  tissues  were
processed and embedded in an OCT compound (Tissue-Tek,
Sakura, CA) for cryosections. Six 10 µm cryosections from
the optic nerve were prepared, and TUNEL was performed
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2752using the ApopTag Red apoptosis detection kit (Chemicon,
CA) according to the manufacturer's protocol. Nuclei were
stained with 10 µg/ml Hoechst bisbenzimide 33258 (Sigma-
Aldrich, MO). Fluorescence images were obtained using Axio
Imager (Carl Zeiss, Oberkochen, Germany), and TUNEL-
positive cells were counted in the outer nuclear layer (ONL)
of the sections, including the optic nerve head.
Measurement of outer nuclear layer thickness: Mice were
anesthetized  with  pentobarbital  sodium  (70  mg/kg  BW),
perfused  with  10  ml  of  PBS  48  h  after  the  start  of  light
exposure,  and  the  eyes  were  then  enucleated.  Paraffin-
embedded retinal sections (3 µm) were prepared and stained
with H&E. ONL thickness was measured at each 0.2 mm point
from the optic nerve head to the most peripheral area using
ImageJ  software  (National  Institutes  of  Health,  Bethesda,
MD), as described previously [16].
Electroretinography:  Electroretinography  (ERG)  analysis
was performed as previously described, 48 h after the start of
light  exposure  [19,20].  Responses  were  differentially
amplified and filtered through a digital bandpass filter ranging
from 0.313 to 1,000 Hz to yield a- and b-waves. Light pulses
of  800  cd·s/m2  and  4  ms  duration  were  delivered  via  a
commercial Ganzfeld stimulator (Ganzfeld System SG-2002;
LKC Technologies, Inc.). The amplitude of the a-wave was
measured from the baseline to the trough of the a-wave, and
the amplitude of the b-wave was determined from the trough
of the a-wave to the peak of the b-wave. The implicit time of
the a- and b-waves was measured from the onset of stimuli to
the peak of each wave.
Statistical analysis: All results are expressed as mean±SD
with n-numbers as indicated. The student’s t-test was used for
statistical  comparison  between  the  groups.  Differences
between the means were considered statistically significant
when the probability values were <0.05.
RESULTS
Establishment of an experimental IOL implantation model in
mice: To mimic the conditions of human cataract surgery and
its effects on the retina, we developed a murine model of IOL
implantation. The surgical procedures for IOL implantation
in mice performed in this study were mostly identical to those
of human cataract surgery (Figure 1). Two-mm diameter IOL
buttons were created from the IOL for clinical use, and the
IOL button without haptics was well stabilized in the capsular
bag. Throughout the present study, IOLs were successfully
implanted in all the animals.
Morphological  study  revealed  that  the  murine  eyes
developed PCO after IOL implantation (Figure 2). Whereas
Figure 1. Extra-capsular crystalline lens
extraction  and  IOL  implantation  in
murine eyes. A-C: Corneal incision with
a  surgical  knife  and  Vannas  scissors.
D:  Continuous  curvilinear
capsulorrhexis  with  forceps.  E:  Lens
extraction  with  hydrodissection.  F:
Inflation  of  the  capsular  bag  with  a
viscoelastic  substance.  G:  Fabricated
IOL buttons (2 mm diameter). H, I: IOL
insertion.  J,  K:  Removal  of  the
viscoelastic substance and closure of the
corneal  wound  with  interrupted  11–0
nylon sutures.
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2753no  cells  existed  underneath  the  posterior  capsule  on
postoperative  day  1  (Figure  2A,C),  lens  epithelial  cell
migration was observed at postoperative day 5 (Figure 2B,D),
indicating that PCO developed a few days after the surgery in
this model. No difference was seen in lens epithelial cell
migration between clear IOL and yellow IOL implantation
(data not shown).
Effects  of  IOL  implantation  on  the  retinal  tissues:  To
determine whether IOL implantation itself impairs the ocular
tissues, particularly the posterior segment of the eyes, we
examined  structural  and  functional  changes  in  the  retinal
tissues after IOL implantation.
First, we studied the apoptotic changes in the retina after
IOL implantation. At 3 days after the surgery, the numbers of
TUNEL-positive cells in clear IOL-implanted eyes (5.8±2.8
cells/section, n=6) showed no significant difference compared
to eyes without IOL implantation (5.3±2.9 cells/section, n=6,
p=0.811, Figure 3A,B). Similarly, the numbers of TUNEL-
positive cells for the clear IOL-implanted eyes resembled
those of the yellow IOL-implanted eyes (5.6±1.6 cells/section,
n=6, p=0.908, Figure 3A,B).
In line with TUNEL, at 7 days after the surgery, the ONL
thickness showed no difference between clear IOL-implanted
eyes (n=5) and eyes without surgery under dim light (n=6,
Figure 3C,D). The ONL thickness in clear IOL-implanted
eyes showed no significant difference when compared with
that of yellow IOL-implanted eyes (n=6, Figure 3C,D).
Furthermore, the ERG amplitude of the a-wave from clear
IOL-implanted mice (0.40±0.09 mV, n=5, Figure 4A,B) or
yellow  IOL-implanted  mice  (0.40±0.05  mV,  n=5,  Figure
4A,B) was not different from that of mice without surgery
under dim light (0.42±0.07 mV, n=5, p=0.82 for clear IOL,
0.76  for  yellow  IOL,  Figure  4A,B).  Similarly,  the  ERG
amplitude  of  the  b-wave  from  clear  IOL-implanted  mice
(0.98±0.17 mV, n=5, Figure 4A,B) or yellow IOL-implanted
mice (0.92±0.23 mV, n=5, Figure 4A,B) was not different
from  that  of  mice  without  surgery  under  dim  light
(1.06±0.14  mV,  n=5,  p=0.41  [compared  with  clear  IOL],
p=0.29 [compared with yellow IOL], Figure 4A,B). These
Figure  2.  Development  of  posterior
capsular  opacity  in  murine  IOL-
implanted  eyes.  Representative
micrographs of murine IOL-implanted
eyes,  stained  with  hematoxylin  and
eosin on post-operative day 1 (A) or day
5 (B) and high-magnification images of
the posterior lens capsule (C, D; square
area marked in A and B, respectively).
The arrows depict lens epithelial cells
migrating  underneath  the  posterior
capsule  on  post-operative  day  5  (D),
whereas  no  cells  were  seen  on  post-
operative day 1 (C). The bar shown in
A  represents  500  µm  and  applies  for
(B)  as  well.  The  bar  shown  in  C
represents 200 µm and applies for (D) as
well.
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2754data  suggest  that  IOL  implantation  itself  elicits  neither
morphological  nor  functional  loss  in  the  retinal  tissue  of
murine eyes. The implicit time showed a similar pattern of no
differences between the groups regarding amplitude (a-wave:
Figure 3. Morphological assessment of
sensory retina in murine IOL-implanted
eyes and control eyes without surgery.
Apoptotic  photoreceptors  and  ONL
thickness after IOL implantation were
assessed under dim light conditions (5
LUX,  12  h  on/off).  A:  (Upper)
Representative  images  of  TUNEL
staining  for  retinal  sections  1  mm
superior  to  the  optic  nerve  head  at
postoperative  day  3.  (Lower)  Merged
images.  Nuclei  were  counterstained
with  Hoechst  33258.  Bar=50  µm.  B:
Quantification of TUNEL-positive cells
in the ONL of each section, including
the optic nerve head. Values are mean
±SD  (n=6  in  each  group).  C:
Representative images of hematoxylin
and eosin staining for retinal sections 1
mm superior to the optic nerve head at
postoperative day 7. Bar represents 50
µm.  D:  ONL  thickness  of  control  or
IOL-implanted eyes. Values are mean
±SD (n=5 to 6 in each group).
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27554.4±0.21 ms for control, 4.2±0.15 ms, p=0.22 [compared with
control] for clear IOL, 4.2±0.19 ms, p=0.19 for yellow IOL;
b-wave: 48.1±2.3 ms for control, 47.2±6.4 ms, p=0.77 for
clear IOL, 46.7±6.1 ms, p=0.51 for yellow IOL, n=5 in each
group, Figure 4C).
Impact of yellow IOL on light-induced retinal degeneration:
To investigate the protective effects of yellow IOL against
light  exposure,  we  conducted  TUNEL,  ONL  thickness
measurement and ERG on retinal tissues of mice that had been
IOL-implanted  with  either  the  clear  or  yellow  lens  and
subjected to 5,000 LUX of white light for 24 h. Since H&E
staining had demonstrated that the PCO developed 2–3 days
after the implantation surgery (Figure 2), we exposed the
animals to light stimulation the day after the surgery.
Whereas animals without light exposure showed no or
very few TUNEL-positive cells in the retina (Figure 3), there
was a dramatically higher number of TUNEL-positive cells
in  the  retina  of  clear  IOL-implanted  animals  after  light
exposure  (266±77  cells/section,  n=6,  Figure  5A,B).  In
contrast to these clear IOL-implanted animals, yellow IOL-
implanted  animals  had  significantly  reduced  numbers  of
TUNEL-positive  cells  after  light  exposure  (153±57  cells/
section, n=6, p<0.01, Figure 5A,B), yet they also showed
higher  numbers  of  cells  than  animals  without  exposure.
Furthermore, animals with yellow IOL implantation retained
the ONL thickness after light exposure compared with clear
IOL implantation (n=7 for clear IOL, n=5 for yellow IOL,
Figure 5C,D). In line with the apoptotic changes in the retinal
tissues,  the  ERG  showed  that  yellow  IOL  implantation
prevents  a  decrease  of  amplitude  in  the  a-wave
(0.18±0.04 mV, versus 0.24±0.02 mV, n=5 in each group,
p<0.05, Figure 6A,B) and b-wave (0.52±0.13 mV, n=5 versus
0.74±0.09 mV, n=5 in each group, p<0.05, Figure 6A,B)
compared with clear IOL implantation after light exposure.
The implicit time showed no differences between the groups
(p=0.42 in the a-wave, p=0.82 in the b-wave, n=5 in each
group, Figure 6C).
DISCUSSION
In the current study, we established a novel in vivo murine
model of IOL implantation. To date, rabbits have generally
been used for the in vivo model of IOL implantation [21].
Mice had not yet been used for this purpose, possibly due to
the difficulty in performing surgery. To our knowledge, the
present study is the first report of an in vivo experiment of
IOL  implantation  in  mice,  which  is  virtually  identical  to
human cataract surgery. We found that the surgical procedures
had  no  deleterious  effects  on  the  retina  and  that  the
phototoxicity data was reproducible. Using this new animal
model for IOL implantation, we found that a yellow-tinted
IOL protected retinal tissue from phototoxicity.
In this study, we implanted a total of 66 IOL buttons into
murine eyes. The surgical procedure to implant the IOLs in
murine eyes required some initial practice time to master, but
it  was  then  possible  to  establish  reproducible  results.
Furthermore, we verified that the morphology and function of
the  sensory  retina  remained  unaffected  by  the  IOL
implantation procedure itself. This indicates the stability and
utility  of  this  model  as  an  experimental  tool  for  cataract
surgery.
The  IOL-implanted  eyes  in  our  model  showed  the
formation of PCO, as in human cataract surgery. In other
experimental animal models, such as rodent models of extra-
capsular crystalline lens extraction without IOL implantation,
multiple layers of lens epithelial cells develop in the center of
the posterior capsule at day 3, and the residual lens epithelial
cells form a new lens only 2 weeks after surgery [14]. By
contrast, in the rabbit model, PCO forms in the eye with IOL
implantation at 2 to 3 weeks after the surgery [21]. Similarly,
in our model a single layer of migrated cells was observed on
the posterior capsule at day 5 postoperatively. Previous and
present data suggest that PCO occurs more frequently and
earlier in rodent eyes than in rabbit eyes. These facts led us to
the idea that the light exposure experiment with the IOL-
implanted mice ought to be conducted on the day following
the surgery.
The  Chesapeake  Bay  Watermen  Study  reported  the
relationship  between  light  exposure  and  the  incidence  of
macular  degeneration  for  the  first  time  [22].  Since  then,
epidemiological  studies  have  indicated  the  relationship
between light exposure and retinal diseases, and prospective
studies have shown that light exposure is a risk factor of early
AMD [8,9,23]. However, other reports have disclaimed the
relationship between sun exposure and macular degeneration
[24]. Hence, the link between phototoxicity and AMD is still
controversial and elucidation of the risk after cataract surgery
on AMD development is important. Previously, other groups
have reported the retinal protective effects of yellow IOL
materials placed in front of the eyes of experimental animals
without crystalline lens removal [15,16]. By contrast, in the
present  study,  we  demonstrate  for  the  first  time  in  vivo
evidence of the protective effects of yellow IOL materials on
biochemical, morphological, and electrophysiological aspects
of the retinal photoreceptors using a novel murine model with
crystalline lens removal and IOL implantation. The current
model of IOL implantation may provide information in the
future on the mechanisms of photoreceptor damage using
short wavelength visible light in AMD development after
cataract surgery [11].
Besides  the  photoreceptors,  RPE  cells  are  the  other
potential  candidates  that  may  play  a  role  in  retinal
phototoxicity,  which  leads  to  the  pathogenesis  of  AMD
[25-27]. In this study, we sought to evaluate light-induced
degeneration of the RPE; however, few apoptotic cells were
found  in  the  RPE  layer  after  light  stimulation,  and  no
difference was detected between the clear IOL- and the yellow
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2756Figure  4.  Functional  assessment  of
sensory retina in murine IOL-implanted
eyes. ERG was measured under dim (5
LUX, 12 h on/off) light at 7 days after
IOL  implantation.  A:  Representative
wave responses from control or IOL-
implanted eyes. B, C: Quantification of
amplitude (B) or implicit time (C) of a-
wave and b-wave. Values are mean ±SD
(n=5 in each group).
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2757Figure 5. Impact of yellow IOL on the
light-induced  retinal  morphological
changes.  A:  (Upper)  Representative
images of TUNEL staining for retinal
sections  1  mm  superior  to  the  optic
nerve head on postoperative day 3 (2
days  after  the  light  exposure  [5,000
LUX, 24 h]). (Lower) Merged images.
Nuclei  were  counterstained  with
Hoechst 33258. Bar represents 50 µm.
B:  Quantification  of  TUNEL-positive
cells  in  the  ONL  of  each  section,
including the optic nerve head. Values
are  mean  ±SD  (n=6  in  each  group;
*p<0.05). C: Representative images of
hematoxylin  and  eosin  staining  for
retinal sections 1 mm superior to the
optic nerve head on postoperative day 7
(6 days after the light exposure [5,000
LUX, 24 h]). Bar represents 50 µm. D:
ONL thickness of IOL-implanted eyes
after light exposure. Values are mean
±SD (n=5 to 7; *p<0.05, **p<0.01).
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2758Figure 6. Protective effects of yellow
IOL  against  light-induced  retinal
functional damage. ERG was measured
at postoperative day 7 (6 days after the
light exposure [5,000 LUX, 24 h]) in
IOL implanted-mice. A: Representative
wave  responses  from  clear  or  yellow
IOL-implanted  eyes.  B,  C:
Quantification  of  amplitude  (B)  or
implicit  time  (C)  of  a-waves  and  b-
waves from each group (n=5 in each
group, respectively; *p<0.05).
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2759IOL implantation group (data not shown). This result might
be due to the experimental design, such as the specific strength
of the light stimulation or the time window of analysis. Further
investigation of the RPE cells is required to gain a better
understanding of their role in phototoxicity.
In summary, we described a new animal model of IOL
implantation  and  demonstrated  the  protective  effects  of
colored-IOL  against  retinal  phototoxicity  after  cataract
surgery. The data showed that our murine IOL implantation
model provides a realistic representation of human cataract
surgery  and  may  facilitate  the  elucidation  of  mechanisms
underlying IOL-associated issues. In future, our model will
allow  for  the  study  of  post-surgical  phototoxicity  in
susceptible disease groups by using various transgenic mice
or animal models of retinal disease.
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